Feasibility and Safety of Same‐Day Discharge Following Radiofrequency Renal Artery Sympathetic Denervation

Simone Fezzi; William J. Gibson; Max Wagener; Darragh Murphy; Eileen Coen; Patrick W. Serruys; Yoshinobu Onuma; Faisal Sharif

doi:10.1161/jaha.123.030742

Related publications

Chapter in a book2012

Interventional treatment of essential hypertension: renal sympathetic denervation

Thomas F. Lüscher, Ulf Landmesser, Mathias Wolfrum, G. Noll, Isabella Sudano, E Eeckout, Patrick W. Serruys, William Wijns, A Vahanian, Marc R.H.M. van Sambeek, Rodney De Palma

Letter2015

Renal denervation reloaded: where to go from here?

Felix Mahfoud, Patrick W. Serruys

EuroIntervention

Article2009

815 SORAFENIB FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA. FEASIBILITY AND SAFETY OUTSIDE RESEARCH TRIALS

María Reig, Alejandro Forner, Jordi Rimola, Carlos Rodríguez de Lope, Carmen Ayuso, Josep M. Llovet, Jordi Bruix

Journal of Hepatology

Article1998

Simultaneous Morphological and Functional Assessment of a Renal Artery Stent Intervention With Intravascular Ultrasound

Stéphane Carlier, Wenguang Li, E.I. Céspedes, Antonius F.W. van der Steen, J Hamburger, N. Bom, Patrick W. Serruys

Circulation

Article2004

1022-80 Safety and feasibility of paclitaxel-eluting stents in the treatment of ST-elevation acute myocardial infarction

Andrew T.L. Ong, Pedro A. Lemos, Angela Hoye, Chourmouzios A. Arampatzis, Francesco Saia, Jiro Aoki, Carlos A.G. van Mieghem, Sjoerd H. Hofma, Pieter C. Smits, Willem J. van der Giessen, Georgios Sianos, Eugène McFadden, Pim de Feyter, Patrick W. Serruys

Journal of the American College of Cardiology